Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Cystic fibrosis airway inflamm...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
Cystic fibrosis airway inflammation enables elexacaftor/tezacaftor/ivacaftor-mediated rescue of N1303K CFTR mutation

Cystic fibrosis airway inflammation enables elexacaftor/tezacaftor/ivacaftor-mediated rescue of N1303K CFTR mutation

Bibliographic Details
Main Authors: Martina Gentzsch, Brooke Baker, Deborah M. Cholon, Charissa W. Kam, Cameron J. McKinzie, Katherine A. Despotes, Susan E. Boyles, Nancy L. Quinney, Charles R. Esther Jr, Carla M.P. Ribeiro
Format: Article
Language:English
Published: European Respiratory Society 2024-01-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/10/1/00746-2023.full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://openres.ersjournals.com/content/10/1/00746-2023.full

Similar Items

  • Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor
    by: Burkhard Tümmler, et al.
    Published: (2023-03-01)
  • Response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis with the N1303K mutation: Case report and review of the literature
    by: Maria G. Tupayachi Ortiz, et al.
    Published: (2024-03-01)
  • Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
    by: Mafalda Bacalhau, et al.
    Published: (2023-03-01)
  • Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    by: Lijia Zhang, et al.
    Published: (2022-12-01)
  • Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor
    by: Filipa C. Ferreira, et al.
    Published: (2024-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs